Profile
ATHA VRTX REGN VRNA ARGX ALNY
Company Name Athira Pharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $26.62M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.03K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Mark J. Litton Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ATHA VRTX REGN VRNA ARGX ALNY
Quant Rating Score 3 4 4 1 4 3
Quant Rating Neutral Buy Buy Strong Sell Buy Neutral
Trading
ATHA VRTX REGN VRNA ARGX ALNY
Last Close $4.6 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $4.7 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.23 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -2.13 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 1900 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ATHA VRTX REGN VRNA ARGX ALNY
1 Month Return 27.07 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 1070.78 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 1591.18 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 897.83 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 684.05 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 609 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ATHA VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ATHA VRTX REGN VRNA ARGX ALNY
Asset Growth -63.32 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 23.76 % 9.09 % -131.37 % 24.59 %
Net Income Growth 17.62 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -69.56 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -1492.21 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -1512.2 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 19.58 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 3.56 % - -143.33 % -107.98 %
Operating 3 Year CFG -116.32 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -2118.39 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -1737.36 % -100 % 40.15 % 97.08 %
EPS Growth 18.45 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 18.45 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -65.97 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -86.6 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 292.72 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 355.33 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -23.22 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 3.81 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ATHA VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -125.61 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -107.06 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -144.12 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 96.07 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -5739.58 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 2.58 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -13.27 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -13.27 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 639.62 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -5739.58 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.38 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -0.38 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -0.38 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ATHA VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 0% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.1B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.1B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -25.2 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ATHA VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.01B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.04B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.06B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ATHA VRTX REGN VRNA ARGX ALNY
Net Income $-0.1B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.1B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to ATHA
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00449 262.96
VTI Vanguard Total Stock Market Index Fund 0.00004 336.65
IBB iShares Biotechnology ETF 0.01 172.5
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
IWN iShares Russell 2000 Value ETF 0.00895 199.97
BIB ProShares Ultra Nasdaq Biotechnology 0 84.7191
VXF Vanguard Extended Market Index Fund 0.00028 216.28
HDG ProShares Hedge Replication ETF 0.000636629 52.7
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.24 39.86
UWM ProShares Ultra Russell2000 0.00141683 53.08
XPH SPDR S&P Pharmaceuticals ETF 0.22 56.84
IWC iShares Micro-Cap ETF 0.00256 166.03
URTY ProShares UltraPro Russell2000 0.00103958 63.07
VTWV Vanguard Russell 2000 Value Index Fund 0.02 176.213
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.03 12.44
BBP Virtus LifeSci Biotech Products ETF 0.24 81.17
ISCB iShares Morningstar Small-Cap ETF 0 69.13
SMLF iShares MSCI USA Small-Cap Multifactor ETF 0 78.86
VUN.TO Vanguard U.S. Total Market Index ETF 0.00004 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00004 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.38
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.36
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.22
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.21
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.21
RYLD Global X Russell 2000 Covered Call ETF 0 15.69
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.11 72.5283
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
DFAU Dimensional US Core Equity Market ETF 0.00017105 47.29
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 29.429
DFUS Dimensional U.S. Equity ETF 0.0000017 74.35
DFAT Dimensional U.S. Targeted Value ETF 0.00000379 66.28
DFAS Dimensional U.S. Small Cap ETF 0.00000184 75.67
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000475 40.79
VTSAX Vanguard Total Stock Market Index Fund 0.00004 163.89
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 8.7175
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00028 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00004 163.92
DFSU Dimensional US Sustainability Core 1 ETF 0.00020915 43.45
IBRN iShares Neuroscience and Healthcare ETF 0.03879 31.5777
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.00020844 16.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00028 164.02
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0.01 64.82
SURI Simplify Propel Opportunities ETF 1.1938 16.2927
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 474.81
DCOR Dimensional ETF Trust 0.0004943 75.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00028 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00004 307.49
Unlock